[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"David Blum\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":67},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,47],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100563375",false,"NCT06615349","DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care","DigiPall; a Randomized Controlled Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care","Inclusion Criteria:\n\n* Patients with established diagnosis of a metastatic cancer\u002Fsevere illness with limited life expectancy receiving palliative care services\n* Estimated life expectancy \\\u003C24 months (physician's guess)\u002F \\>3 months\n* Karnofsky Index ≥ 50% \u002F ECOG≤ 2\n* Aged \\>18 years\n* Owns and uses a smartphone\n* Give written informed consent\n\nExclusion Criteria:\n\n* Patients under curative treatment\n* Relevant cognitive impairment","ALL","18 Years",{"count":18,"type":19},382,"ESTIMATED","INTERVENTIONAL",[22],"NA","The aim of this study is to test if a system consisting of a wearable device measuring heartbeats and steps, together with daily communication with a chatbot on the smartphone asking the patients about their symptoms and giving tips, can reduce unplanned hospital readmissions and improve well-being in advanced cancer and severely ill patients.",[25,26],"Terminal Illness","Terminal Cancer",[28,29,30,31,32,33],"Palliative Care","chatbot","wearable","PROMs","rehospitalisation","mobile health","RECRUITING","2025-07-07",{"date":37,"type":38},"2025-07-10","ACTUAL",{"date":40,"type":38},"2025-06-11",{"date":42,"type":19},"2027-09",{"name":44,"class":45},"David Blum","OTHER",1,{"id":48,"slug":4,"hasResults":10,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":52,"targetDuration":4,"studyType":20,"phases":54,"briefSummary":55,"conditions":56,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":46},"100535342","NCT06250582","Does Virtual Reality Improve Symptom Burden in Dialysis Patients?","Inclusion Criteria:\n\n* Older than 18 years;\n* in treatment with thrice-weekly hemodialysis sessions;\n* regular hemodialysis duration of three to five hours\n* having no visual impairment\n* having no acoustic deficit\n* patient must be capable of speaking and understanding German or English\n* no signs of cognitive impairment\n* patient oriented in time and space\n* being able to give informed consent as documented by signature\n\nExclusion Criteria:\n\n* diagnosis of epilepsy\n* current pregnancy",{"count":53,"type":19},20,[22],"The goal of this clinical trial is to investigate the use of virtual reality therapy in dialysis patients. The main question it aims to answer is: Does virtual reality improve symptom burden in dialysis patients and improve their mental wellbeing? Over a period of one month, one virtual reality therapy session of 30 minutes will be performed during each regular hemodialysis session. Since we will conduct a monocentric, crossover randomized controlled trial, the participants act as their own control group.",[57,58],"Dialysis","Virtual Reality","2025-04-23",{"date":61,"type":38},"2025-04-27",{"date":63,"type":38},"2024-12-02",{"date":65,"type":19},"2025-12-31",{"name":44,"class":45},""]